-
Company Insights
Innovation and Patenting activity of Extra Space Storage Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Extra Space Storage Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval Analysis for Chromosomal Disorders
Overview How likely is it that the drugs in Chromosomal Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chromosomal Disorders Overview Chromosomal disorders arise from irregularities in chromosome structure or...
-
Product Insights
NewLikelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelabresib in Essential Thrombocythemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelabresib in Essential Thrombocythemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelabresib in Essential Thrombocythemia Drug Details: Pelabresib (CPI-0610) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Neuroendocrine Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-764532 in Neuroendocrine Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Neuroendocrine Carcinoma Drug Details: OBT-620 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-764532 in Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Glioma Drug Details: OBT-620 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Neuroendocrine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-764532 in Neuroendocrine Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Neuroendocrine Cancer Drug Details: OBT-620 is under development for the...
-
Product Insights
NewUnited Kingdom (UK) Travel Insurance Distribution Dynamics by Channels and Future Market, 2023 Update
United Kingdom (UK) Travel Insurance Market Report Overview The UK travel insurance market research report offers insights into consumer purchasing decisions within the travel insurance scenario and discusses their influence on the market over the next few years. In 2023, more than 24% of travel insurance purchases were via PCWs, which suggests that consumers want more details from their providers about their coverage levels, policy options, and premium pricing. Additionally, single-trip policies maintained their popularity during the year Leading Distribution...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelabresib in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelabresib in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelabresib in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details: Pelabresib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-764532 in Small-Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Small-Cell Lung Cancer Drug Details: OBT-620 is under development...